These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5128029)

  • 1. Differentiated storage mechanisms for noradrenaline and dopamine in the rabbit heart.
    Shahab L; Lishajko F; von Euler US
    Neuropharmacology; 1971 Nov; 10(6):765-9. PubMed ID: 5128029
    [No Abstract]   [Full Text] [Related]  

  • 2. 3,4-Dihydroxyphenylalanine (dopa), dopamine and norepinephrine storage in the rat heart after L-dopa--further evidence for norepinephrine release.
    Landsberg L; Bruno SJ
    Biochem Pharmacol; 1973 Feb; 22(3):417-25. PubMed ID: 4687136
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative aspects of the replacement of norepinephrine by dopamine as a sympathetic transmitter after inhibition of dopamine-beta-hydroxylase by disulfiram.
    Thoenen H; Haefely W; Gey KF; Huerlimann A
    J Pharmacol Exp Ther; 1967 May; 156(2):246-51. PubMed ID: 6026255
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenylethyldithiocarbamate: a new dopamine-beta-hydroxylase inhibitor.
    Jonsson J; Grobecker H; Gunne LM
    J Pharm Pharmacol; 1967 Mar; 19(3):201-3. PubMed ID: 4382347
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of disulfiram and ascorbic acid on catecholamine content in rat brain.
    Izquierdo JA; Jofré IJ; Acevedo C
    J Pharm Pharmacol; 1972 Apr; 24(4):330-2. PubMed ID: 4402844
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetic analysis of stimulation-evoked overflow of noradrenaline and dopamine beta-hydroxylase from the isolated rabbit heart. The effect of DOPA decarboxylase inhibition.
    Muscholl E; Spira FJ
    Neuroscience; 1982; 7(12):3201-11. PubMed ID: 7162634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for inhibition of dopamine-beta-hydroxylase in vivo after sub-acute pyrazole treatment in rats.
    MacDonald E; Pispa JP
    Med Biol; 1977 Oct; 55(5):284-91. PubMed ID: 22792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine beta-hydroxylase inhibition reveals a selective influence of endotoxin on catecholamine content of rat tissues.
    Arnold J; Choo JJ; Little RA; Rothwell NJ
    Circ Shock; 1990 Aug; 31(4):387-94. PubMed ID: 2204497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diethyldithiocarbamate and structurally-related compounds and the uptake and release of noradrenaline in the heart of the rat.
    Lippmann W; Lloyd K
    J Pharm Pharmacol; 1969 Nov; 21(11):780-1. PubMed ID: 4390840
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic oral treatment with disulfiram on dopamine-beta-hydroxylase and biogenic amines.
    Lippmann W
    Eur J Pharmacol; 1968 Apr; 3(1):84-6. PubMed ID: 5654674
    [No Abstract]   [Full Text] [Related]  

  • 12. [The replacement of noradrenaline by dopamine as a postganglionic sympathetic transmitter in the inhibition of dopamine beta-hydroxylase by disulfiram].
    Thoenen H; Haefely W; Gey KF; Hürlimann A
    Helv Physiol Pharmacol Acta; 1966 Nov; 68():C118-9. PubMed ID: 5987882
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
    Cohen Y; Wepierre J; Jacquot C; Rapin J
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of acetaldehyde on the noradrenaline content in the isolated heart from normal and disulfiram-treated guinea-pigs.
    Moller SE
    Acta Pharmacol Toxicol (Copenh); 1971; 30(5):440-8. PubMed ID: 5172278
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery.
    Soares-da-Silva P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):219-23. PubMed ID: 3762736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo.
    Musacchio JM; Goldstein M; Anagnoste B; Poch G; Kopin IJ
    J Pharmacol Exp Ther; 1966 Apr; 152(1):56-61. PubMed ID: 5937402
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine accumulation after dopamine beta-hydroxylase inhibition in rat heart as an index of norepinephrine turnover.
    Fuller RW; Snoddy HD; Perry KW
    Life Sci; 1982 Aug; 31(6):563-70. PubMed ID: 6290819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of neuronal noradrenaline and dopamine beta-hydroxylase release by a sodium-deficient solution substituted with urea.
    Muscholl E; Ritzel H
    Neuroscience; 1980; 5(2):441-52. PubMed ID: 7374952
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice.
    Bourdélat-Parks BN; Anderson GM; Donaldson ZR; Weiss JM; Bonsall RW; Emery MS; Liles LC; Weinshenker D
    Psychopharmacology (Berl); 2005 Nov; 183(1):72-80. PubMed ID: 16163519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of noradrenaline in the isolated perfused rat heart after depletion with decaborane.
    Bhattacharya IC
    Acta Physiol Scand; 1968; 73(1):128-38. PubMed ID: 5672442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.